TENS in Nocturnal Enuresis
ConditionNocturnal Enuresis in Children
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-16
SponsorSuez Canal University
About this trial
Paracascral transcutaneous electrical nerve stimulation (PTENS) is a credible therapeutic option for nocturnal enuresis. The investigators shall investigate whether maintenance PTENS after initial response improves durability of remission compared with observation alone.
Eligibility criteria
Qualifiers
Diagnosis of primary monosymptomatic nocturnal enuresis (PMNE) based on International Children's Continence Society (ICCS) criteria.
Persistent symptoms after at least 8 weeks of standardized urotherapy, including counseling on timed voiding, evening fluid management, and bowel optimization.
Baseline severity of ≥3 wet nights per week on a 14-night diary.
Ability of the child and caregiver to complete diaries and comply with home treatment and follow-up.
Disqualifiers
Non-monosymptomatic enuresis, daytime urgency, daytime incontinence, dysfunctional voiding, or significant post-void residual.
Neurogenic bladder, spinal dysraphism, cerebral palsy, epilepsy uncontrolled on treatment, or other neurologic diseases affecting lower urinary tract function.
Congenital or acquired urinary tract abnormalities.
Active urinary tract infection.
Trial design
Treatments tested in this trial
- transcutaneous electrical nerve stimulation
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov